Re-evaluating Severe Cutaneous Adverse Events to Enfortumab Vedotin: TEC rather than TEN
Published: 15 September 2026| Version 1 | DOI: 10.17632/g7zd6hggj5.1
Contributor:
Description
Supplementary material for letter for the Journal of the American Academy of Dermatology (JAAD).
Files
Categories
Drug Adverse Reactions